High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00247143|
Recruitment Status : Unknown
Verified September 2006 by Lampiris, Harry W., M.D..
Recruitment status was: Recruiting
First Posted : November 1, 2005
Last Update Posted : September 20, 2006
|Condition or disease||Intervention/treatment||Phase|
|HIV AIDS||Drug: Kaletra (drug)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Prospective Open Label Non-Comparative Study of the Safety, Efficacy and Tolerability of High Dose Ritonavir/Lopinavir Liquid in Salvage Therapy for PI Resistant HIV & a PK Equivalence Sub-Study of High Dose Ritonavir/Lopinavir Capsules|
|Study Start Date :||October 2005|
- To evaluate the safety and efficacy of high dose kaletra liquid and capsules in the treatment of highly antiretroviral experienced, protease inhibitor resistant HIV disease.
- To compare traditional pharmacokinetic measures of the two formulations (kaletra liquid and kaletra capsules) in a subset of the patients included in the primary analysis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00247143
|Contact: Harry W. Lampiris, M.D.||firstname.lastname@example.org|
|Contact: Sandra Charles, R.N.||415-221-4810 ext email@example.com|
|United States, California|
|San Francisco VA Medical Center||Recruiting|
|San Francisco, California, United States, 94121|
|Principal Investigator: Harry W. Lampiris, M.D.|
|Principal Investigator:||Harry W. Lampiris, M.D.||San Francisco Veterans Affairs Medical Center|